FDA Recalls Regadenoson Injection for Missing Label Information
Baxter Healthcare Corporation is recalling 60,594 units of Regadenoson Injection nationwide due to missing label information on affected lot numbers. Healthcare providers with affected lots should contact the manufacturer for replacement supplies.
- Product
- REGADENOSON — REGADENOSON (REGADENOSON)
- Category
- Drug
- Distribution
- Distributed nationwide